The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Metabolic Reprogramming in Glioma
Open accessAbstract
Many cancers have long been thought to primarily metabolize glucose for energy production-a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the early twentieth century. Yet cancer cells also utilize other substrates, such as amino acids and fatty acids, to produce raw materials for cellular maintenance and energetic currency to accomplish cellular tasks. The contribution of these substrates is increasingly appreciated in the context of glioma, the most common form of malignant brain tumor. Multiple catabolic pathways are used for energy production within glioma cells, and are linked in many ways to anabolic pathways supporting cellular function. For example: glycolysis both supports energy production and provides carbon skeletons for the synthesis of nucleic acids; meanwhile fatty acids are used both as energetic substrates and as raw materials for lipid membranes. Furthermore, bio-energetic pathways are connected to pro-oncogenic signaling within glioma cells. For example: AMPK signaling links catabolism with cell cycle progression; mTOR signaling contributes to metabolic flexibility and cancer cell survival; the electron transport chain produces ATP and reactive oxygen species (ROS) which act as signaling molecules; Hypoxia Inducible Factors (HIFs) mediate interactions with cells and vasculature within the tumor environment. Mutations in the tumor suppressor p53, and the tricarboxylic acid cycle enzymes Isocitrate Dehydrogenase 1 and 2 have been implicated in oncogenic signaling as well as establishing metabolic phenotypes in genetically-defined subsets of malignant glioma. These pathways critically contribute to tumor biology. The aim of this review is two-fold. Firstly, we present the current state of knowledge regarding the metabolic strategies employed by malignant glioma cells, including aerobic glycolysis; the pentose phosphate pathway; one-carbon metabolism; the tricarboxylic acid cycle, which is central to amino acid metabolism; oxidative phosphorylation; and fatty acid metabolism, which significantly contributes to energy production in glioma cells. Secondly, we highlight processes (including the Randle Effect, AMPK signaling, mTOR activation, etc.) which are understood to link bio-energetic pathways with oncogenic signals, thereby allowing the glioma cell to achieve a pro-malignant state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–239 of 239
Chen, H., Lu, Q., Fei, X., Shen, L., Jiang, D., & Dai, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-4575-8 · Cited by 64
DeHaan, C. L., Habibi-Nazhad, B., Yan, E., Salloum, N., Parliament, M. B., & Allalunis‐Turner, J. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-19 · Cited by 63
Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
Misirkic-Marjanovic, M., Janjetović, K., Vucicevic, L. M., Tovilović-Kovačević, G., Ristic, B. Z., Vilimanovich, U., Harhaji-Trajkovic, L. M., Šumarac-Dumanović, M., Micić, D., Bumbasirevic, V. Z., et al. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.08.003 · Cited by 62
LKB1 reduces ROS-mediated cell damage via activation of p38
Xu, H.-G., Zhai, Y.-X., Chen, J., Lu, Y., Wang, J.-W., Quan, C.-S., Zhao, R.-X., Xiao, X., He, Q., Werle, K. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.315 · Cited by 60
Zhang, B., Chen, J., Cheng, A. S. L., & Ko, B. C. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084931 · Cited by 58
Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export
Rodríguez-Vargas, J. M., Rodríguez, M. I., Majuelos‐Melguizo, J., García-Díaz, Á., González-Flores, A., López‐Rivas, A., Virág, L., Illuzzi, G., Schreiber, V., Dantzer, F., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.80 · Cited by 57
Mitochondria in Cancer Stem Cells: A Target for Therapy
Loureiro, R., Mesquita, K. A., Oliveira, P. J., & Vega‐Naredo, I. (2013) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/18722148113079990006 · Cited by 55
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
Han, D., Wei, W., Chen, X., Zhang, Y., Wang, Y., Zhang, J., Wang, X., Yu, T., Hu, Q., Liu, N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4444 · Cited by 53
Yuan, S., Lu, Y., Yang, J., Chen, G., Kim, S., Feng, L., Ogasawara, M. A., Hammoudi, N., Lu, W., Zhang, H., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0174-2 · Cited by 53
Integrative modelling of tumour DNA methylation quantifies the contribution of metabolism
Mehrmohamadi, M., Mentch, L., Clark, A. G., & Locasale, J. W. (2016) · Nature Communications · doi:10.1038/ncomms13666 · Cited by 51
Bhatia, B., Potts, C. R., Guldal, C. G., Choi, S., Korshunov, A., Pfister, S. M., Kenney, A. M., & Nahle, Z. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0968-6 · Cited by 50
IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma
Sinha, S., Koul, N., Dixit, D., Sharma, V., & Sen, E. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.024 · Cited by 48
Lee, J., Park, J., Kwon, O., Lee, T.-H., Nakano, I., Miyoshi, H., Chun, K., Park, M., Lee, H. J., Kim, S. U., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou145 · Cited by 47
p53 regulates the mevalonate pathway in human glioblastoma multiforme
Laezza, C., D’Alessandro, A., Croce, L. D., Picardi, P., Ciaglia, E., Pisanti, S., Malfitano, A. M., Comegna, M., Faraonio, R., Gazzerro, P., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.279 · Cited by 47
Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling
Gao, P., Yang, C., Nesvick, C. L., Feldman, M. J., Sizdahkhani, S., Liu, H., Chu, H., Yang, F., Tang, L., Tian, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7710 · Cited by 47
Bhattacharya, K., Maiti, S., & Mandal, C. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.34 · Cited by 47
Prabhu, A. H., Sarcar, B., Miller, C. R., Kim, S.-H., Nakano, I., Forsyth, P. A., & Chinnaiyan, P. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou369 · Cited by 44
Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma
Kambach, D. M., Halim, A. S., Cauer, A. G., Sun, Q., Tristan, C. A., Celiku, O., Kesarwala, A. H., Shankavaram, U. T., Batchelor, E., & Stommel, J. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14740 · Cited by 44
Han, D., Zhang, J., Wei, W., Tao, T., Hu, Q., Wang, Y., Wang, X., Liu, N., & You, Y. (2015) · Tumor Biology · doi:10.1007/s13277-014-3024-4 · Cited by 40
Sun, H., Zhang, M., Cheng, K., Li, P., Han, S., Li, R., Su, M., Zeng, W., Liu, J., Guo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12803 · Cited by 40
Lloyd, R. E. I., Keatley, K., Littlewood, D. T. J., Meunier, B., Holt, W. V., An, Q., Higgins, S. C., Polyzoidis, S., Stephenson, K. F., Ashkan, K., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov020 · Cited by 39
Reconstructed Metabolic Network Models Predict Flux-Level Metabolic Reprogramming in Glioblastoma
Özcan, E., & Çakır, T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00156 · Cited by 35
AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas
Guo, D., Cloughesy, T. F., Radu, C. G., & Mischel, P. S. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10540 · Cited by 34
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
Ellis, H. P., & Kurian, K. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00052 · Cited by 33
Ching, J., Amiridis, S., Stylli, S. S., Bjorksten, A. R., Kountouri, N., Zheng, T. W., Paradiso, L., Luwor, R. B., Morokoff, A. P., O'Brien, T. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4019 · Cited by 33
García, M. R., Foretz, M., Viollet, B., Prieto, A., Fraga, M., García‐Caballero, T., Costoya, J. A., & Señarís, R. M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.014 · Cited by 32
mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment
Masui, K., Cavenee, W. K., & Mischel, P. S. (2015) · Brain Pathology · doi:10.1111/bpa.12307 · Cited by 31
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme
Vidone, M., Clima, R., Santorsola, M., Calabrese, C., Girolimetti, G., Kurelac, I., Amato, L. B., Iommarini, L., Trevisan, E., Leone, M., et al. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.027 · Cited by 31
Fuchs, S. A., Peeters‐Scholte, C. M. P. C. D., de Barse, M. M. J., Roeleveld, M. W., Klomp, L. W. J., Berger, R., & de Koning, T. J. (2011) · Amino Acids · doi:10.1007/s00726-011-1086-9 · Cited by 27
Intersections between mitochondrial sirtuin signaling and tumor cell metabolism
Herrera, K. N. G., Lee, J. J., & Haigis, M. C. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1031879 · Cited by 26
Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
Macedo, G. S., da Motta, L. L., Giacomazzi, J., Netto, C. B. O., Manfredini, V., Vanzin, C. S., Vargas, C. R., Hainaut, P. L., Klamt, F., & Ashton‐Prolla, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047010 · Cited by 26
Isakovic, A. M., Dulović, M., Marković, I., Kravic‐Stevovic, T., Bumbasirevic, V. Z., Trajković, V., & Isaković, A. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.001 · Cited by 25
Shi, Y., Tao, T., Liu, N., Luan, W., Qian, J., Li, R., Hu, Q., Yan, W., Zhang, J., & You, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13170 · Cited by 22
Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma
Clark, P. M., Mai, W. X., Cloughesy, T. F., & Nathanson, D. A. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0613-6 · Cited by 21
Woolf, E. C., & Scheck, A. C. (2012) · CNS Oncology · doi:10.2217/cns.12.9 · Cited by 17
Simulation Predicts IGFBP2-HIF1α Interaction Drives Glioblastoma Growth
Lin, K. W., Liao, A., & Qutub, A. A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004169 · Cited by 16
Yang, X., Dong, Q., Li, L., Huo, J., Li, P.-Q., Fei, Z., & Zhen, H. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.019 · Cited by 13
Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology?
Aldea, M. D., Tomuleasa, C., Petrushev, B., Șușman, S., Kacso, G. I., Irimie, A. I., Florian, I. Ş., & Soritau, O. (2011) · PubMed · Cited by 9
Lemaire, L. P., Franconi, F., Siegler, B., Legendre, C., & Garcion, E. (2015) · Tumor Biology · doi:10.1007/s13277-015-3458-3 · Cited by 9
Cited by
Role of Glutathione in Cancer: From Mechanisms to Therapies
Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
Pajak, B., Siwiak, E., Sołtyka, M., Priebe, A., Zieliński, R., Fokt, I., Ziemniak, M., Jaśkiewicz, A., Borowski, R., Domoradzki, T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010234 · Cited by 574
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
Liu, H., Qin, S., Liu, C., Jiang, L., Li, C., Yang, J., Zhang, S., Yan, Z., Liu, X., Yang, J., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00674-y · Cited by 58
Metadata
- Authors
- Strickland, M., & Stoll, E. A.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-26
- Volume
- 5
- Pages
- 43-43
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2607640564
- Cited by
- 345
- References
- 239
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.